Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation

详细信息    查看全文

• 作者：Daniel Lozano ; Miguel Manzano ; Juan Carlos Doadrio ; Antonio J. Salinas ; Marí ; a Vallet-Regí ; Enrique Gó ; mez-Barrena ; Pedro Esbrit
• 关键词：Osteostatin ; Osteoblastic growth and differentiation ; PTHrP ; Silica-based bioceramics
• 刊名：Acta Biomaterialia
• 出版年：2010
• 出版时间：March 2010
• 年：2010
• 卷：6
• 期：3
• 页码：797-803
• 全文大小：612 K

文摘

Parathyroid hormone-related protein (PTHrP) is an important regulator of bone remodeling. Recent studies show that this protein can induce osteogenic features through its N- and C-terminal domains. Silica-based ordered mesoporous bioceramics with an SBA-15 structure – known to be bioactive and biocompatible – have recently been evaluated for their capacity to uptake and deliver L-tryptophan. This amino acid corresponds to the end position of the 107–111 domain (called osteostatin) of the native C-terminal PTHrP (107–139) fragment, whose true action in bone metabolism is still ill-defined. In the present study, we assessed some effects of the aforementioned biomaterials pressed into disks, loaded or not with osteostatin, in osteoblastic cell cultures. Our data demonstrate that both unmodified and organically modified SBA-15 loaded with this peptide increase cell growth and the expression of several osteoblastic products (alkaline phosphatase, osteocalcin, collagen, osteoprotegerin, receptor activator of nuclear factor-κB ligand and vascular endothelial growth factor) in osteoblastic cells. These findings support the notion that osteostatin coating confers osteogenic features to silica-based ordered mesoporous materials, which make them suitable biomaterials for bone repair.